Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,892 | -67,485 | -33,279 | -15,020 | 1,419 |
| Depreciation Amortization | 13 | 53 | 41 | 28 | 15 |
| Income taxes - deferred | -19,568 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,137 | -4,835 | -5,980 | -6,495 | -4,124 |
| Other Working Capital | 3,028 | -3,541 | -9,294 | -11,506 | -6,686 |
| Other Operating Activity | 4,374 | 32,375 | 20,250 | 15,282 | 7,861 |
| Operating Cash Flow | $-21,908 | $-43,433 | $-28,262 | $-17,711 | $-1,515 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -57,020 | -525,813 | -448,551 | -363,252 | -149,763 |
| Sale Of Investment | 91,731 | 192,038 | 130,638 | 70,932 | 12,037 |
| Investing Cash Flow | $34,711 | $-333,775 | $-317,913 | $-292,320 | $-137,726 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 800 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 1,588 | 270,549 | 267,847 | 267,268 | 267,268 |
| Other Financing Activity | 1,153 | -1,765 | -1,765 | -1,765 | -2,688 |
| Financing Cash Flow | $3,541 | $268,784 | $266,082 | $265,503 | $264,580 |
| Beginning Cash Position | 59,774 | 168,198 | 168,198 | 168,198 | 168,198 |
| End Cash Position | 76,118 | 59,774 | 88,105 | 123,670 | 293,537 |
| Net Cash Flow | $16,344 | $-108,424 | $-80,093 | $-44,528 | $125,339 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,908 | -43,433 | -28,262 | -17,711 | -1,515 |
| Free Cash Flow | -21,908 | -43,433 | -28,262 | -17,711 | -1,515 |